7-124897155-A-G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS1
The NM_015450.3(POT1):c.9+10T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000353 in 1,445,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
 Genomes: 𝑓 0.00022   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000014   (  0   hom.  ) 
Consequence
 POT1
NM_015450.3 intron
NM_015450.3 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.229  
Publications
0 publications found 
Genes affected
 POT1  (HGNC:17284):  (protection of telomeres 1) This gene is a member of the telombin family and encodes a nuclear protein involved in telomere maintenance. Specifically, this protein functions as a member of a multi-protein complex that binds to the TTAGGG repeats of telomeres, regulating telomere length and protecting chromosome ends from illegitimate recombination, catastrophic chromosome instability, and abnormal chromosome segregation. Increased transcriptional expression of this gene is associated with stomach carcinogenesis and its progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008] 
POT1 Gene-Disease associations (from GenCC):
- pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- tumor predisposition syndrome 3Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
- glioma susceptibility 9Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- thyroid gland carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- cerebroretinal microangiopathy with calcifications and cysts 3Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76). 
BP6
Variant 7-124897155-A-G is Benign according to our data. Variant chr7-124897155-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 475110.Status of the report is criteria_provided_single_submitter, 1 stars. 
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000217 (33/151964) while in subpopulation AFR AF = 0.000794 (33/41556). AF 95% confidence interval is 0.00058. There are 0 homozygotes in GnomAd4. There are 20 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| POT1 | NM_015450.3 | c.9+10T>C | intron_variant | Intron 5 of 18 | ENST00000357628.8 | NP_056265.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.000230  AC: 35AN: 151848Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
35
AN: 
151848
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000483  AC: 11AN: 227954 AF XY:  0.0000162   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
11
AN: 
227954
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000139  AC: 18AN: 1293070Hom.:  0  Cov.: 22 AF XY:  0.00000925  AC XY: 6AN XY: 648752 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 exome 
 AF: 
AC: 
18
AN: 
1293070
Hom.: 
Cov.: 
22
 AF XY: 
AC XY: 
6
AN XY: 
648752
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
18
AN: 
28834
American (AMR) 
 AF: 
AC: 
0
AN: 
39378
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
24122
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
37590
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
77768
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52314
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5308
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
973456
Other (OTH) 
 AF: 
AC: 
0
AN: 
54300
 ⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.0000739012), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.383 
Heterozygous variant carriers
 0 
 1 
 2 
 2 
 3 
 4 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.000217  AC: 33AN: 151964Hom.:  0  Cov.: 32 AF XY:  0.000269  AC XY: 20AN XY: 74286 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
33
AN: 
151964
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
20
AN XY: 
74286
show subpopulations 
African (AFR) 
 AF: 
AC: 
33
AN: 
41556
American (AMR) 
 AF: 
AC: 
0
AN: 
15218
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10616
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
286
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
67790
Other (OTH) 
 AF: 
AC: 
0
AN: 
2104
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 2 
 4 
 5 
 7 
 9 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
Tumor predisposition syndrome 3    Benign:1 
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.